LogoLogoMSF Science Portal
  • My saved items
logo

© Médecins Sans Frontières

MSF Science Portal
About MSF Science Portal
About MSF
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use

v2.1.4829.produseast1

Conference Material > Slide Presentation

Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial

Solomos A, Musa AM, Mbui J, Mohammed R, Olobo J, Ritmeijer KKD, Alcoba G, Muthoni Ouattara G, Egondi T, Nakanwagi P, Omollo T, Wasunna M, Alvar J, Alves F
Download
Download
Countries
EthiopiaKenyaUgandaSudan
Subject Area
pediatricsneglected tropical diseaseskala azarleishmaniasis
DOI
10.57740/81jj-tz57
Published Date
07-Jun-2023
Languages
English
Conference
MSF Scientific Day International 2023

Linked Items

Conference Material > Abstract
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial
07-Jun-2023
Conference Material > Video
Efficacy and safety of 14-day treatment with paromomycin and miltefosine for primary visceral leishmaniasis in eastern Africa: non-inferiority trial
07-Jun-2023